{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:50:18Z","timestamp":1786791018881,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P21-04949"],"award-info":[{"award-number":["P21-04949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymthe.2023.07.004","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T21:54:20Z","timestamp":1689285260000},"page":"2600-2611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adenoviral vectors infect B lymphocytes in\u00a0vivo"],"prefix":"10.1016","volume":"31","author":[{"given":"Paul J.","family":"Rice-Boucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Andrade","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluet Borrego","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria J.","family":"Sturtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reka","family":"Lorincz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Pingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-6014","authenticated-orcid":false,"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.07.004_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41591-022-01765-8","article-title":"Engineered cellular immunotherapies in cancer and beyond","volume":"28","author":"Finck","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2023.07.004_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fonc.2019.00196","article-title":"Beyond CAR T\u00a0cells: Other cell-based immunotherapeutic strategies against cancer","volume":"9","author":"Patel","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.2100340","article-title":"Vector Strategies to Actualize B Cell\u2013Based Gene Therapies","volume":"207","author":"Jeske","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020003792","article-title":"Immunotherapy perspectives in the new era of B-cell editing","volume":"5","author":"Ueda","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2023.07.004_bib6","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.ymthe.2021.09.019","article-title":"Genome edited B cells: a new frontier in immune cell therapies","volume":"29","author":"Rogers","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2017.11.012","article-title":"Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells","volume":"26","author":"Hung","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib8","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1038\/s41598-018-30358-0","article-title":"Engineering of Primary Human B cells with CRISPR\/Cas9 Targeted Nuclease","volume":"8","author":"Johnson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.07.004_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymthe.2021.10.027","article-title":"Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire","volume":"30","author":"Ou","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20190287","article-title":"HIV-specific humoral immune responses by CRISPR\/Cas9-edited B cells","volume":"216","author":"Hartweger","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.07.004_bib11","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1038\/s41467-020-20304-y","article-title":"Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.07.004_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T\u00a0cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2023.07.004_bib13","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.07.004_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","article-title":"In\u00a0vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib15","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ymthe.2022.05.018","article-title":"Precision medicine: In\u00a0vivo CAR therapy as a showcase for receptor-targeted vector platforms","volume":"30","author":"Michels","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib16","first-page":"5702","article-title":"Combining T-cell-specific activation and in\u00a0vivo gene delivery through CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2023.07.004_bib17","article-title":"Bispecific binder redirected lentiviral vector enables in\u00a0vivo engineering of CAR-T cells","volume":"9","author":"Huckaby","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2023.07.004_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1671761","article-title":"In\u00a0vivo generated human CAR T\u00a0cells eradicate tumor cells","volume":"8","author":"Agarwal","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2023.07.004_bib19","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"In\u00a0vivo generation of human CD19-CAR T\u00a0cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2023.07.004_bib20","author":"Sheldon"},{"key":"10.1016\/j.ymthe.2023.07.004_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/v15020358","article-title":"A Renaissance for Oncolytic Adenoviruses?","volume":"15","author":"Blanchette","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.07.004_bib22","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/v13122502","article-title":"Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy","volume":"13","author":"Watanabe","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2023.07.004_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jconrel.2020.09.003","article-title":"Adenoviral vectors for in\u00a0vivo delivery of CRISPR-Cas gene editors","volume":"327","author":"Boucher","year":"2020","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2023.07.004_bib24","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/bloodadvances.2019000706","article-title":"High-level protein production in erythroid cells derived from in\u00a0vivo transduced hematopoietic stem cells","volume":"3","author":"Wang","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2023.07.004_bib25","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.ymthe.2019.08.006","article-title":"Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In\u00a0Vivo HSC Transduction with HDAd5\/35++ Vectors","volume":"27","author":"Li","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib26","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1873-3468.13668","article-title":"Adenovirus vectors in hematopoietic stem cell genome editing","volume":"593","author":"Li","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2023.07.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"npj Vaccin."},{"key":"10.1016\/j.ymthe.2023.07.004_bib28","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ymthe.2022.01.034","article-title":"Adenovirus-based vaccines\u2014a platform for pandemic preparedness against emerging viral pathogens","volume":"30","author":"Coughlan","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.virol.2013.09.020","article-title":"Retargeting of gene expression using endothelium specific hexon modified adenoviral vector","volume":"447","author":"Kaliberov","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2023.07.004_bib30","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib31","article-title":"An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.004_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgm.1530","article-title":"Creation of a panel of vectors based on ape adenovirus isolates","volume":"13","author":"Roy","year":"2011","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2023.07.004_bib33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I study of DNX-2401 (delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib34","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3892\/mmr.2017.6974","article-title":"Selection of an optimal promoter for gene transfer in normal B cells","volume":"16","author":"Winiarska","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2023.07.004_bib35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2008-09-177139","article-title":"Engineering human hematopoietic stem\/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in\u00a0vitro maturation to human B lymphocytes","volume":"113","author":"Luo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.07.004_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/viro.1998.9440","article-title":"Characterisation of Regulatory Sequences at the Epstein\u2013Barr VirusBamHI W Promoter","volume":"252","author":"Bell","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2023.07.004_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.07.004_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2023.07.004_bib60","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","article-title":"Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob","volume":"72","author":"Krasnykh","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.07.004_bib37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0002-9440(10)65223-6","article-title":"The Role of B Lymphocytes in Coxsackievirus B3 Infection","volume":"155","author":"Mena","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.72.1.415-419.1998","article-title":"The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses","volume":"72","author":"Bergelson","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus Binding to a Plasma\u00a0Membrane Receptor Triggers Interleukin-1\u03b1-Mediated Proinflammatory Macrophage Response In\u00a0Vivo","volume":"31","author":"Di Paolo","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.004_bib40","first-page":"750","article-title":"Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs","volume":"2","author":"Wickham","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fchem.2019.00489","article-title":"Novel Ligands Targeting \u03b14\u03b21 Integrin: Therapeutic Applications and Perspectives","volume":"7","author":"Baiula","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ymthe.2023.07.004_bib42","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/1873-3468.13649","article-title":"Interaction of adenovirus with antibodies, complement, and coagulation factors","volume":"593","author":"Allen","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2023.07.004_bib43","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2023.07.004_bib44","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"Atasheva","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.07.004_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molimm.2006.02.030","article-title":"Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis","volume":"44","author":"Zhang","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2023.07.004_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114189","article-title":"In\u00a0vivo editing of the pan-endothelium by immunity evading simian adenoviral vector","volume":"158","author":"Lorincz","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymthe.2023.07.004_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41434-018-0003-1","article-title":"Targeted in\u00a0vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR\/Cas9","volume":"25","author":"Stephens","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.004_bib49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2019.02.009","article-title":"Long-term correction of hemophilia B using adenoviral delivery of CRISPR\/Cas9","volume":"298","author":"Stephens","year":"2019","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2023.07.004_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103643","article-title":"High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2023.07.004_bib51","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","article-title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors","volume":"101","author":"Chuah","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.07.004_bib52","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.07.004_bib53","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1093\/nar\/gky1286","article-title":"Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing","volume":"47","author":"Haldeman","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2023.07.004_bib54","doi-asserted-by":"crossref","first-page":"12918","DOI":"10.1128\/JVI.01531-07","article-title":"Identification of a New Human Adenovirus Protein Encoded by a Novel Late l-Strand Transcription Unit","volume":"81","author":"Tollefson","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.004_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.07.004_bib56","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2023.07.004_bib57","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/s41467-022-33787-8","article-title":"Ex\u00a0vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in\u00a0vivo","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:06:38Z","timestamp":1778616398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623003842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525001623003842"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoviral vectors infect B lymphocytes in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}